Filter by: patients
What is sitagliptin?

Sitagliptin is an antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 47 10 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Other 7 0
hard to control blood sugars 5 1 Efficacy_slight
Weight gain 1 1 Efficacy_none
Polycystic Ovary Syndrome (PCOS) 1 1 Efficacy_none
General health 1 0

See all 68 patients currently taking sitagliptin

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
11

Reported Dosages

  25 mg daily 100 mg m,w,f 50 mg daily 100 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 12 Number of Patients: 12 55 Number of Patients: 55  

Reported Stop Reasons

Why Patients Stopped Taking sitagliptin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 2   Expense: 40%
Other 2   Other: 40%
Doctor's advice 1   Doctor's advice: 20%

See all 5 patients who’ve stopped taking sitagliptin

Currently Taking sitagliptin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking sitagliptin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of sitagliptin

Always
10 91%
Usually
1 9%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of sitagliptin

Very
0 0%
Somewhat
0 0%
A little
1 9%
Not at all
10 91%

Cost

Paid out of pocket

Cost of sitagliptin

$200+
0 0%
$100-199
0 0%
$50-99
2 29%
$25-49
0 0%
< $25
4 57%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.